Gloria Matthews, Ankasa Regenerative Technologies - Novel Regenerative Medicine | LSI USA '24

Ankasa is developing ART352-L as a novel regenerative medicine. ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Gloria Matthews
Gloria Matthews
Ankasa Regenerative Technologies